PETQ

PetIQ, Inc. operates as a pet medication and wellness company. It operates in two segments, Products and Services. The company offers Rx pet medications, which include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and co-develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

Gross Profit (TTM): 135188000

Market Capitalization: 659910000

Operating Margin (TTM): 0.0451

PE Ratio: None

PEG Ratio: 1.095

Profit Margin: -0.0061

Revenue Per Share (TTM): 32.95

Revenue (TTM): 900100000

Quarterly Earnings Growth YOY: 0

Quarterly Revenue Growth YOY: 0.299

Trailing PE: -

Diluted EPS (TTM): -0.209

Dividend Date: None

Dividend Per Share: None

Dividend Yield: 0%

EBITDA: 75442000

ExDividend Date: None

Forward Annual Dividend Rate:

Forward Annual Dividend Yield: